Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
The ‘obesity paradox’: Weight gain during hospitalization for stroke may improve survival
ORLANDO, Fla. — For individuals hospitalized with intracerebral hemorrhage, increased caloric intake that led to an increase in weight was associated with higher odds of survival after 3 months, according to a poster.
Vaping strongly correlates with cognitive function in young adults
ORLANDO, Fla. — In a cohort of South American young adults, those who smoked or vaped recorded lower scores on a cognitive assessment vs. those who did not, with a stronger correlation found between vapers and lower cognitive scores, data show.
VIDEO: Three takeaways on cognition and brain health during menopause
CHICAGO — In this Healio video exclusive, Pauline M. Maki, PhD, provides three takeaways from her talk on cognition and hormone therapy during menopause at the Annual Meeting of The Menopause Society.
Log in or Sign up for Free to view tailored content for your specialty!
Delayed dual antiplatelet therapy significantly reduces new stroke occurrence at 90 days
Initiating dual antiplatelet therapy within 72 hours of symptom onset in patients with ischemic stroke or transient ischemic attack led to a significant reduction in new stroke occurrence at 90 days, according to results of a subgroup analysis.
FDA clears transcutaneous electrical nerve stimulation device for chronic pain
The FDA has granted clearance to a Colorado-based medical technology company’s transcutaneous electrical nerve stimulation device for those suffering from chronic pain, according to a press release.
Depressive symptoms linked to amyloid accumulation, suggesting ties to preclinical AD
Increasing depressive symptoms among cognitively unimpaired older adults appeared significantly associated with early amyloid accumulation in brain regions involved in emotional control, according to a study published in JAMA Network Open.
Diabetes drug linked to reduced risk for several types of dementia
Type 2 diabetes has emerged as a possible risk factor contributing to the development of dementia, but one class of agents used to treat the disease may provide greater protective effects, study results published in BMJ showed.
SGLT2 inhibitors tied to similar dementia risk as dulaglutide in type 2 diabetes
SGLT2 inhibitors and dulaglutide confer a similar risk for dementia among adults aged 60 years and older with type 2 diabetes, according to findings published in Annals of Internal Medicine.
Any level of physical activity linked to improved brain health
Individuals who engaged in some form of exercise or physical activity on a regular or semi-regular basis demonstrated better brain health compared with inactive individuals, according to research from Nature Aging.
‘Concerning trends’ in dementia mortality most notable among Black adults, women in US
Mortality data from 1999 to 2020 revealed an upward trend in dementia-related mortality in the United States, especially among Black adults and women, according to a study published in The Primary Care Companion for CNS Disorders.
-
Headline News
‘The mind is medicine’: How virtual reality can cool bothersome hot flashes
September 18, 20244 min read -
Headline News
CDC: Close contact of Missouri bird flu case had symptoms but was not tested
September 17, 20242 min read -
Headline News
Metformin use may lower risk for long COVID in adults with type 2 diabetes
September 18, 20243 min read
-
Headline News
‘The mind is medicine’: How virtual reality can cool bothersome hot flashes
September 18, 20244 min read -
Headline News
CDC: Close contact of Missouri bird flu case had symptoms but was not tested
September 17, 20242 min read -
Headline News
Metformin use may lower risk for long COVID in adults with type 2 diabetes
September 18, 20243 min read